+1,738.2%
DRUG vs SPY
+70.8%
+1,667.4%
-80.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.9% | -0.3% | -3.1% |
| 7D | -6.2% | -1.7% | -4.5% | -7.1% |
| 30D | -55.9% | -3.1% | -52.9% | -56.6% |
| 3M | -70.4% | -4.5% | -66.0% | -71.2% |
| 6M | -70.8% | +0.6% | -71.4% | -70.7% |
| YTD | -71.0% | +9.4% | -80.4% | -69.5% |
| 1Y | -60.9% | +11.3% | -72.3% | -58.2% |
| 3Y | +1,738.2% | +70.4% | +1,667.8% | +1,606.3% |
| All | +1,738.2% | +70.8% | +1,667.4% | +1,606.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SPY.
Daily Out/Under-Performance
Portfolio return minus SPY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling